ERn Financial’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$211K Buy
+312
New +$185K 0.03% 159
2025
Q2
– Sell
-1,663
Closed -$827K – 179
2025
Q1
$827K Sell
1,663
-210
-11% -$114K 0.13% 110
2024
Q4
$975K Buy
1,873
+50
+3% +$27.5K 0.15% 100
2024
Q3
$1.13M Sell
1,823
-28
-2% -$16.6K 0.17% 90
2024
Q2
$1.02M Buy
1,851
+32
+2% +$18.3K 0.17% 92
2024
Q1
$1.06M Buy
1,819
+29
+2% +$16.3K 0.18% 90
2023
Q4
$975K Buy
1,790
+62
+4% +$30K 0.18% 89
2023
Q3
$875K Buy
1,728
+163
+10% +$86.9K 0.19% 92
2023
Q2
$817K Buy
1,565
+25
+2% +$13.5K 0.17% 98
2023
Q1
$887K Buy
1,540
+29
+2% +$16.3K 0.2% 89
2022
Q4
$832K Buy
1,511
+100
+7% +$53K 0.19% 91
2022
Q3
$715K Sell
1,411
-33
-2% -$18.5K 0.18% 88
2022
Q2
$785K Buy
1,444
+549
+61% +$302K 0.19% 87
2022
Q1
$529K Buy
+895
New +$514K 0.12% 103

Other funds holding TMO

ERn Financial's TMO Position: Q3 2026 in Review

ERn Financial opened a new position in Thermo Fisher Scientific (TMO) in Q3 2026: 312 shares worth $211K. The stake represents 0.03% of the portfolio and ranks #159 among its holdings. This is a return to the name: ERn Financial previously reported a position in TMO as recently as Q1 2025.

ERn Financial first reported a position in TMO in Q1 2022 and has held it in 14 quarters since. The position peaked at $1.13M in Q3 2024. 2,806 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • ERn Financial held 312 shares of Thermo Fisher Scientific worth $211K as of Q3 2026.
  • Thermo Fisher Scientific was a new ERn Financial position in Q3 2026.
  • Thermo Fisher Scientific made up 0.03% of ERn Financial's portfolio in Q3 2026, its #159 holding.
  • ERn Financial first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 14 quarters since.
  • ERn Financial's Thermo Fisher Scientific position peaked at $1.13M in Q3 2024.
  • 2,806 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on ERn Financial's 13F filing for Q3 2026, filed 28 Oct 2026.